With cancer cases steadily rising in India, the need for accessible and affordable treatment has never been greater. According to the Indian Council of Medical Research (ICMR), over 14 lakh new cancer cases were reported in 2023, while nearly 100 out of every one lakh people are diagnosed with cancer each year. Against this backdrop, health experts have welcomed the government’s recent decision to waive basic customs duty on 17 essential cancer drugs, calling it a much-needed step toward easing the financial burden on patients.
Policy Relief Brings Hope to Patients
As per the press release, medical professionals believe that the real impact of this announcement will emerge when patients experience tangible relief. Dr. Arun Kumar Giri, Director – Surgical Oncology, Aakash Healthcare, said that while the budget announcement marks an important policy shift, its success depends on timely implementation. He noted that pharmacies and hospitals have already begun adjusting prices, and patients are hopeful that the benefits will soon translate into lower treatment costs.
World Cancer Day Highlights Patient-Centric Care
Coinciding with this policy decision, World Cancer Day is being observed under the theme ‘United by Unique’, which highlights the importance of personalised and patient-centric cancer care. Dr. Puneet Gupta, Chairman – Oncology Services, Asian Hospital, said that timely and affordable access to medicines plays a critical role in improving recovery outcomes. When patients can start treatment without delays or financial stress, their chances of successful recovery improve significantly.
He further added that the duty exemption allows hospitals to plan cancer treatments more efficiently and ensures that life-saving therapies reach patients when they need them most.
Expanding Cancer Care Beyond Urban Centres
Experts also pointed out that the burden of cancer treatment is increasing in rural areas and smaller towns, where access to insurance remains limited. Dr. Puneet emphasised that alongside affordable medicines, strengthening detection and treatment facilities in government hospitals can significantly improve disease control and save lives across underserved regions.
Strengthening the Healthcare Ecosystem
Echoing this view, Dr. Jaipalreddy, Consultant – Surgical Oncology, Jupiter Hospital, Pune, described the budget announcement as part of a broader effort to strengthen healthcare access in India. He explained that along with customs duty exemptions, investments in regional healthcare hubs and training of caregivers will make cancer care more efficient and comprehensive. As a result, patients will benefit not only from affordable medicines but also from improved support throughout their treatment journey.
Improving Access to Specialised Cancer Therapies
Focusing on specialised care, Dr. Vineet Malhotra, Head of Urology and Director, VNA Hospital, highlighted how reduced import duties will make advanced cancer treatments more affordable. He explained that several therapies rely on imported or rare drugs that were previously priced beyond the reach of many patients. By lowering import costs, hospitals can ensure timely access to the right treatment while easing both financial and health-related stress.
A Step Towards Patient-Focused Cancer Care
Dr. Arun Kumar Giri further noted that the decision to reduce prices of life-saving cancer drugs aligns closely with the goal of delivering patient-focused and accessible cancer care. For thousands of families battling cancer, this move represents more than a policy change—it offers renewed hope, better care options, and a more secure future.
Positive Implications for Health Insurance Coverage
Meanwhile, financial experts believe the government’s move could also improve health insurance coverage. With lower drug prices, insurance providers may find it easier to cover treatment costs, thereby reducing out-of-pocket expenses for patients. As Dr. Arun explained, policyholders who previously faced high co-payments or claim rejections for imported or specialty drugs may now benefit from broader coverage. This shift could encourage more patients to seek timely treatment without fear of financial hardship.